Rowatinex Gastro-resistant Capsules, Soft
Authorisation PA0074/009/001 · Rowa Pharmaceuticals Limited,
- Licence holder
- Rowa Pharmaceuticals Limited, (all products →)
- Active substances
- Beta pinene, Cineole, Camphene, Alpha pinene, Fenchone, Anethole, Borneol
- Dosage form
- Gastro-resistant capsule, soft
- Route of administration
- Oral use
- First authorised
- 01/04/1983
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Beta pinene: supply and approvals
2 authorised products on the HPRA list contain Beta pinene. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 12 Oct 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 12 Oct 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 12 Oct 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Cineole: supply and approvals
2 authorised products on the HPRA list contain Cineole. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 12 Oct 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 12 Oct 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 12 Oct 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Camphene: supply and approvals
2 authorised products on the HPRA list contain Camphene. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 12 Oct 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 12 Oct 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 12 Oct 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 13 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.